User:ArcuateArt
Editor·5,744 edits·since 2025/02
ArcuateArt is an editor on PeptidePedia Wiki, editing since 2025 / 2.
This editor works mainly on incretin biology and receptor pharmacology. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
5,744Total edits
26Logged here
20Articles touched
2025/02Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is incretin biology and receptor pharmacology.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| GLP-1 receptor | 2 | 37 | 5% |
| Insulin secretion | 2 | 31 | 6% |
| Albumin binding half-life extension | 1 | 28 | 4% |
| Qingdao Saber Technology Pharmaceutical | 1 | 28 | 4% |
| Wuhan Wansheng Biotechnology | 1 | 39 | 3% |
| Beta cell function | 1 | 31 | 3% |
| Enteroendocrine L cell | 1 | 30 | 3% |
| Dose escalation schedule | 1 | 33 | 3% |
| Chinese Peptide Company | 1 | 44 | 2% |
| Electrospray ionisation | 1 | 28 | 4% |
| Glucagon-like peptide-1 | 1 | 41 | 2% |
| Dulaglutide | 1 | 26 | 4% |
| Arcuate nucleus | 1 | 31 | 3% |
| Satiety signalling | 1 | 28 | 4% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.